Biogen, with sales falling sharply, posts ‘obviously disappointing’ Aduhelm sales of $300K, CEO Vounatsos saysnews2021-10-20T14:47:23+00:00October 20th, 2021|Fierce Pharma|
Roche gets a boost from COVID-19 drug Actemra, but Ocrevus lags as patients prep for boostersnews2021-10-20T14:39:10+00:00October 20th, 2021|Fierce Pharma|
Pfizer strong-armed governments in COVID-19 vaccine supply talks, report saysnews2021-10-20T14:34:23+00:00October 20th, 2021|Fierce Pharma|
Merck recalls 22K vials of Cubicin after customer finds glass shardnews2021-10-20T13:21:11+00:00October 20th, 2021|Fierce Pharma|
AstraZeneca’s Soliris needs a 97% to 98% discount in myasthenia gravis, ICER saysnews2021-10-20T13:18:27+00:00October 20th, 2021|Fierce Pharma|
On heels of GBT Oxbryta campaign, ad agency launches pharma comms division, Riester RXnews2021-10-19T20:41:52+00:00October 19th, 2021|Fierce Pharma|
Lupin recalls blood pressure tablets on cancer-causing contamination concernsnews2021-10-19T16:06:34+00:00October 19th, 2021|Fierce Pharma|
Despite legal troubles, Johnson & Johnson is in the financial driver’s seat for 2022 and beyond, CFO saysnews2021-10-19T15:38:07+00:00October 19th, 2021|Fierce Pharma|
Failed cancer immunotherapies cost Medicare hundreds of millions. How should FDA revamp accelerated approvals?news2021-10-19T15:04:34+00:00October 19th, 2021|Fierce Pharma|
WHO plots multibillion-dollar campaign to buy COVID-19 antivirals for $10 per course: Reutersnews2021-10-19T14:32:27+00:00October 19th, 2021|Fierce Pharma|
